Softball Fields Sample Clauses

Softball Fields. As consideration for the License of the Premises, and at Licensee’s sole cost and expense, Licensee shall construct the Softball Fields. The Softball Fields shall be approximately 7.5 acres and shall be constructed in strict compliance with the plans, specifications, and drawings approved by City and only upon the granting of all applicable permits. The Softball Fields shall be comprised of a total of a maximum of three softball fields, a scoreboard for each field, storage space, and a parking lot. Licensee may, at its option, construct the Softball Fields in phases, provided that the first phase shall include two softball fields with dugouts, a gravel parking lot and an access road to the fields from East Street. Upon completion of the initial phase and approval of the improvements by the City, the City and Licensee may enter into the Use Agreement for the first phase improvements, which may be expanded later to include additional improvements.
Sample 1
AutoNDA by SimpleDocs
Softball Fields. The Softball Fields may be used by Foundation for fastpitch softball activities at no charge. Foundation will develop and implement a fee schedule in consultation with the City for the Xxxxxxx Fastpitch Complex, which fee schedule, including any future changes to the fee schedule, shall be subject to City’s reasonable approval, and charge user groups in accordance with the established fee schedule. Such fees shall be collected by the Foundation and used for the purpose of maintaining, repairing and improving the Premises in accordance with this Agreement. As provided in this Agreement, City may reserve use of the Softball Fields for City use at no charge. Subject to the advance reservation of the Softball Fields by either Party, Foundation shall permit use of the Softball Fields by other user groups in accordance with Section
Sample 1
Softball Fields. Softball fields maintenance consists of grass management, fertilization, and disease control, mowing, edging, mound and plate preparation, and infield playing surface maintenance, on a regular basis and after games scheduled by Foundation.
Sample 1
Softball Fields. District will maintain the softball fields throughout the school year. City may schedule use of the softball fields when not in conflict with District activities. City will maintain the agrilime infields and backstops of softball diamonds during the summer season when in use for City recreation programs.
Sample 1
Softball Fields a. The District will ensure that the School’s Varsity and JV softball teams are provided with practice and competitive facilities that are equivalent in number, quality, use, and maintenance, to the facilities provided to the School’s Varsity and JV baseball teams. This will include, but is not limited to, the following features for each softball facility: i. A safe and adequate softball field for games and practice, including an appropriate sand and clay mixture for the infield; ii. A fence around the entire playing field; iii. Covered home and visitor dugouts; iv. A new backstop; v. Seating that provides adequate spectator capacity; vi. Maintenance, cleaning, and security services similar to the baseball facilities; b. By June 30, 2015, the District will provide OCR with its plan, including a proposed timeline, to provide equivalent Varsity and JV softball practice and competitive facilities. c. After the District’s plan is approved by OCR, at the interval of every six months, the District will provide OCR with reports discussing the progress and completion toward the following milestones: i. approval of the plan by the District’s Board; ii. solicitation and receipt of bids of construction of the facility or facilities; iii. documentation (including photographs) that construction has begun on the facility or facilities; iv. documentation (including photographs) that the facility or facilities are complete and operational.
Sample 1

Related to Softball Fields

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Research License Each Collaborator shall allow the other Collaborator to practice any of its Non- Subject Inventions for the purpose of performing the Cooperative Work. No license, express or implied, for commercial application(s) is granted to either Collaborator in Non-Subject Inventions by performing the Cooperative Work. For commercial application(s) of Non-Subject Inventions, a license must be obtained from the owner.

  • Licensed Technology (a) LICENSOR is not aware of any interference, infringement, misappropriation, or other conflict with any intellectual property rights of third parties, and LICENSOR has never received any charge, complaint, claim, demand, or notice alleging any such interference, infringement, misappropriation, or violation (including any claim that LICENSOR must license or refrain from using any intellectual property rights of any third party). To the knowledge of LICENSOR, no third party has interfered with, infringed upon, misappropriated, or otherwise come into conflict with any of the LICENSED TECHNOLOGY. (b) Exhibit A identifies each patent or registration which has been issued to LICENSOR with respect to any of the LICENSED TECHNOLOGY and identifies each pending patent application or application for registration which LICENSOR has made with respect to any of the LICENSED TECHNOLOGY. LICENSEE acknowledges that LICENSOR has previously made available to LICENSEE correct and complete copies of all such patents, registrations and applications (as amended to-date) in LICENSOR’s possession and has made available to LICENSEE correct and complete copies of all other written documentation in LICENSOR’s possession evidencing ownership and prosecution (if applicable) of each such item. (c) Exhibit A identifies each item of LICENSED TECHNOLOGY that is assigned to LICENSOR or that LICENSOR uses pursuant to license, sublicense, agreement, or permission. LICENSOR has made available to LICENSEE correct and complete copies of all such licenses, sublicenses, agreements, patent prosecution files and permissions (as amended to-date) in LICENSOR’s possession. With respect to each item of LICENSED TECHNOLOGY required to be identified in Exhibit A and to the knowledge of LICENSOR: (i) the license, sublicense, agreement, or permission covering the item is legal, valid, binding, enforceable, and in full force and effect; (ii) the license, sublicense, agreement, or permission will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the consummation of the transactions contemplated hereby; (iii) no Party to the license, sublicense, agreement, or permission is in breach or default, and no event has occurred which with notice or lapse of time would constitute a breach or default or permit termination, modification, or acceleration thereunder; (iv) no party to the license, sublicense, agreement, or permission has repudiated any provision thereof; (v) the underlying item of LICENSED TECHNOLOGY is not subject to any outstanding lien or encumbrance, injunction, judgment, order, decree, ruling, or charge; (vi) no action, suit, proceeding, hearing, investigation, charge, complaint, claim, or demand is pending or is threatened which challenges the legality, validity, or enforceability of the underlying item of LICENSED TECHNOLOGY; and (vii) except as provided in Exhibit A, LICENSOR has not granted any license or similar right to the LICENSED TECHNOLOGY within the GENERAL FIELD or PARTHENOGENESIS FIELD.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Background IP As between the Parties, each Party will retain all right, title and interest in and to all of its Background IP.

  • Library Borrowing privileges available without charge. Upon retirement an employee shall be issued a permanent individual library card.

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!